Evidence mapPaperPMID 41426478Full record

ArticleFrontiers in sleep2023

Sleep apnea endotypes: from the physiological laboratory to scalable polysomnographic measures.

Eysteinn Finnsson, Eydís Arnardóttir, Wan-Ju Cheng, Raichel M Alex, Þóra B Sigmarsdóttir, Snorri Helgason, Liang-Wen Hang, Jón S Ágústsson, Andrew Wellman, Scott A Sands

Abstract read
In one paragraph

Article in Frontiers in sleep, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Current Updates on Pharmacotherapy for Obstructive Sleep Apnea.Journal of rhinology : official journal of the Korean Rhinologic Society · 2026
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eysteinn Finnsson *Nox Research, Nox Medical ehf, Reykjavík, Iceland.
Eydís Arnardóttir *Nox Research, Nox Medical ehf, Reykjavík, Iceland.
Wan-Ju ChengNational Center for Geriatrics and Welfare Research, National Health Research Institutes, Miaoli, Taiwan.
Raichel M AlexDivision of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Þóra B SigmarsdóttirNox Research, Nox Medical ehf, Reykjavík, Iceland.
Snorri HelgasonNox Research, Nox Medical ehf, Reykjavík, Iceland.
Liang-Wen HangSchool of Nursing and Graduate Institute of Nursing, China Medical University, Taichung, Taiwan.
Jón S ÁgústssonNox Research, Nox Medical ehf, Reykjavík, Iceland.
Andrew WellmanDivision of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Scott A SandsDivision of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.

Funding

Predicting response to non-PAP therapies in OSA using PSG-derived endotypesR01HL102321 · BRIGHAM AND WOMEN'S HOSPITAL · 2025 to 2025
$796k
NHLBI NIH HHS R01 HL102321
6 · The paper itself

Abstract

Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent upper airway obstruction during sleep. Despite the availability of continuous positive airway pressure (CPAP) as the gold standard treatment, it is not well tolerated by all patients. Accordingly, research has increasingly focused on developing methods for OSA endotyping, which aims to identify underlying pathophysiological mechanisms of the disorder to help guide treatment for CPAP-intolerant individuals. Four key endotypic traits have been identified, namely: collapsibility, upper airway muscle compensation, arousal threshold and loop gain. However, most methods for extracting these traits require specialized training and equipment not available in a standard sleep clinic, which has hampered the ability to assess the full impact of these traits on OSA outcomes. This paper aims to provide an overview of current methods for OSA endotyping, focusing on the Endo-Phenotyping Using Polysomnography (PUP) method and its cloud-based extension, PUPpy, which offer scalable and accessible ways to estimate endotypic traits from standard polysomnography. We discuss the potential for these methods to facilitate precision medicine for OSA patients and the challenges that need to be addressed for their translation into clinical practice.

Indexed as

endotypingpathophysiologyphenotypingprecision medicinesleep disordered breathing

Identifiers

PMID41426478
PMCPMC12713878

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.